| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |